CFMS News and Press, Conformis Inc. From 04/11/22

BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the market opens on Wednesday, May 4, 2022, at approximately 7:00 a.m. Eastern Time. Mark August...

Conformis (NASDAQ:CFMS) has appointed Michael Fillion as its Chief Operating Officer. Most recently, Michael Fillion has served as the Executive Vice President, Global Operations for Tecomet, a contract manufacturing company with a focus in medical devices. The board has grante...

BILLERICA, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to announce the addition of Michael Fillion as Chief Operating Officer. Mike brings to...

BILLERICA, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic marketing partnership with Synchrony (NYSE: SYF) that will add the innovative Image-to-Implant ...

BILLERICA, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of Directors at the Company’s 2022 Annual Meeting of Stockholders, scheduled to be held on...

Conformis, Inc. (CFMS) Q4 2021 Earnings Conference Call March 2, 2022 4:30 P.M. ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - Chief Financial Officer Conference Call Participants Kyle Rose - Canaccord Steven Lichtman - Oppenheimer Josh Jennings - Cowe...

Shares of Conformis (NASDAQ:CFMS) are down 0.5% in after-hours trading after the company's Q4 2021 results missed on the top and bottom lines. Net loss in the quarter widened ~141% to ~$16M (-$0.09 per basic and diluted share) compared to Q4 20209. Revenue of $15.4M was a 7.8% year-...

ConforMIS press release (NASDAQ:CFMS): Q4 GAAP EPS of -$0.09 misses by $0.02. Revenue of $15.4M (-7.8% Y/Y) misses by $0.21M. For further details see: ConforMIS GAAP EPS of -$0.09 misses by $0.02, revenue of $15.4M misses by $0.21M

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2021. Fourt...

Orthopedic devices company Conformis (CFMS +0.9%) said it is suspending deliveries of its products as well as business development in Russia. The company recently entered into a distribution agreement for its devices in the country. "While we were looking forward to working with our agents an...